Healthpeak Properties (NYSE:DOC) Stock Rating Lowered by Wall Street Zen

Wall Street Zen lowered shares of Healthpeak Properties (NYSE:DOC - Free Report) from a hold rating to a sell rating in a report published on Monday morning.

DOC has been the subject of a number of other reports. Argus reiterated a "buy" rating and issued a $25.00 price objective on shares of Healthpeak Properties in a research report on Tuesday, April 29th. Robert W. Baird lowered their price objective on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research report on Tuesday, April 29th. Wedbush lowered their price objective on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research report on Monday, April 28th. Scotiabank lowered their price objective on Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating for the company in a research report on Monday, May 12th. Finally, Wells Fargo & Company decreased their target price on Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating for the company in a research report on Monday, June 2nd. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and nine have issued a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $23.27.

Healthpeak Properties Stock Performance

Shares of DOC traded down $0.25 during mid-day trading on Monday, hitting $17.97. The company's stock had a trading volume of 6,445,136 shares, compared to its average volume of 5,336,337. Healthpeak Properties has a one year low of $16.64 and a one year high of $23.26. The company has a debt-to-equity ratio of 1.01, a quick ratio of 1.35 and a current ratio of 1.35. The firm has a market capitalization of $12.48 billion, a PE ratio of 44.93, a price-to-earnings-growth ratio of 2.08 and a beta of 1.03. The stock's 50-day moving average is $17.43 and its two-hundred day moving average is $19.00.

Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 EPS for the quarter, hitting the consensus estimate of $0.46. The firm had revenue of $702.89 million during the quarter, compared to analysts' expectations of $690.76 million. Healthpeak Properties had a return on equity of 3.06% and a net margin of 9.99%. Healthpeak Properties's quarterly revenue was up 15.9% compared to the same quarter last year. During the same period last year, the business earned $0.45 earnings per share. As a group, sell-side analysts anticipate that Healthpeak Properties will post 1.86 EPS for the current year.

Healthpeak Properties Announces Dividend

The firm also recently disclosed a dividend, which was paid on Friday, May 30th. Stockholders of record on Tuesday, May 20th were issued a dividend of $0.1017 per share. This represents a dividend yield of 7.05%. The ex-dividend date of this dividend was Monday, May 19th. Healthpeak Properties's dividend payout ratio (DPR) is presently 305.00%.

Insider Activity

In other Healthpeak Properties news, Director Tommy G. Thompson acquired 5,777 shares of the business's stock in a transaction dated Wednesday, May 28th. The shares were acquired at an average price of $17.27 per share, for a total transaction of $99,768.79. Following the acquisition, the director directly owned 144,290 shares of the company's stock, valued at approximately $2,491,888.30. This trade represents a 4.17% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Scott M. Brinker acquired 11,337 shares of the business's stock in a transaction dated Monday, April 28th. The shares were acquired at an average price of $17.68 per share, for a total transaction of $200,438.16. Following the acquisition, the chief executive officer directly owned 201,863 shares in the company, valued at $3,568,937.84. This represents a 5.95% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired 29,764 shares of company stock worth $521,909 in the last 90 days. Corporate insiders own 0.23% of the company's stock.

Institutional Investors Weigh In On Healthpeak Properties

Several institutional investors have recently bought and sold shares of DOC. Norges Bank bought a new stake in Healthpeak Properties in the 4th quarter valued at approximately $166,804,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of Healthpeak Properties by 584.6% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 9,218,848 shares of the real estate investment trust's stock worth $186,405,000 after purchasing an additional 7,872,150 shares during the last quarter. Nuveen LLC acquired a new position in shares of Healthpeak Properties during the 1st quarter worth approximately $124,113,000. Resolution Capital Ltd acquired a new position in shares of Healthpeak Properties during the 4th quarter worth approximately $122,795,000. Finally, Long Pond Capital LP acquired a new position in shares of Healthpeak Properties during the 4th quarter worth approximately $86,885,000. Institutional investors own 93.57% of the company's stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.